Some 13 million Americans struggle with post-traumatic stress disorder (PTSD). Existing therapies only bring relief for a fraction of patients, and new treatments are sorely needed, according to psychiatrists wrestling with the scale of the problem. So, there was distinct disappointment when an advisory committee at the US Food and Drug Administration (FDA) voted earlier this month against a therapy that many had hoped could offer the first new treatment for PTSD in 25 years.

A number of experts who study psychedelics have since spoken out in support of MDMA-assisted therapy for PTSD and have sharply criticised the recommendations of the FDA’s Psychopharmacological Drugs Advisory Committee. But some are still optimistic that the treatment might be approved when the FDA delivers its final decision in August.

Ahead of the meeting, FDA approval of MDMA-assisted therapy for PTSD seemed likely, says Sandeep Nayak, an assistant professor of psychiatry at Johns Hopkins University, who investigates psychedelics as treatments for substance use and mood disorders. About two-thirds of people who received three sessions of MDMA and talk therapy no longer qualified for a PTSD diagnosis at the end of two Phase 3 clinical trials.

It’s an outcome that is “almost double that of existing medications”, says Gül Dölen, a neuroscientist at the University of California, Berkeley, who researches the mechanisms of how psychedelics achieve therapeutic effects. “What’s more, [the treatment] led to durable improvements in these patients lasting at least six months.”

  • Varyk@sh.itjust.works
    link
    fedilink
    arrow-up
    2
    arrow-down
    7
    ·
    6 months ago

    As I said, there’s no reason why not two.

    Similarly, there’s no reason to make people wait for a potential mdma medication while psilocybin is available, effective against the exact same symptoms, perfectly safe and has a simpler therapy regimen.

    • girlfreddy@lemmy.caOP
      link
      fedilink
      arrow-up
      7
      ·
      6 months ago

      Because not everyone is exactly the same. Different experiences, different histories, different types of injuries/traumas means different methods of treatment.

      Yes psilocybin is good. But it may not be for everyone.

      • Varyk@sh.itjust.works
        link
        fedilink
        arrow-up
        2
        arrow-down
        6
        ·
        6 months ago

        Nobody argued everyone’s the same.

        All of the arguments that are put forth for using MDMA to treat PTSD symptoms already work for over 80% of patients using a single treatment of psilocybin that is already available.

        Go ahead and research MDMA, but don’t deny people an available, effective, safe and simple treatment while we wait for the development of experimental therapies.

          • Varyk@sh.itjust.works
            link
            fedilink
            arrow-up
            1
            arrow-down
            8
            ·
            6 months ago

            It’s fine if you didn’t read or don’t like that study.

            Those symptoms resolved by psilocybin are the same as the PTSD symptoms that MDMA hopes to treat one day.

            You not liking a particular medication doesn’t make it less effective or safe for people.

            You might want to check out the news recently though, MDMA is specifically not being approved last weekend this week because a safe therapy has not been found, unlike with psilocybin.

            Psilocybin is safe, simple and effective.

            Controlled studies have born this out.

            • flamingarms
              link
              fedilink
              arrow-up
              7
              ·
              6 months ago

              You do know the hope is not to treat symptoms but underlying disorders, right?

              • Varyk@sh.itjust.works
                link
                fedilink
                arrow-up
                1
                arrow-down
                5
                ·
                6 months ago

                That’s close.

                Ptsd is much more effectively treated when you deal with the symptoms and the disorder itself instead of just focusing on The disorder and ignoring the symptoms.

                Luckily, psilocybin therapies work on both symptoms and disorders.

                I mentioned symptoms specifically because MDMA therapies are specifically focused on the symptoms right now that psilocybin already effectively treats.

                So you can take the effective and perfectly safe psilocybin therapy regimen to alleviate symptoms and the disorder itself while focusing on supplementing that treatment with more traditional therapies to dig deeper into the disorder.

              • Varyk@sh.itjust.works
                link
                fedilink
                arrow-up
                1
                arrow-down
                6
                ·
                6 months ago

                I remember you had those blinders about MDMA.

                It’s easier for you to believe whatever it is you believe than to accept the scientific and therapeutic conclusions that disagree with your beliefs.

                Ask for slanting the narrative. However you feel like it, yeah go for broke.

                The numbers and consistent facts make it pretty easy for me to fix your mistakes anyway.

                  • Varyk@sh.itjust.works
                    link
                    fedilink
                    arrow-up
                    1
                    arrow-down
                    6
                    ·
                    6 months ago

                    You claim to identify external projection by critiquing your own misunderstandings and assumptions about others.

                    I’m glad you personally like Molly and find it helpful.

                    It doesn’t change how effective and safe psilocybin is.

                    You can like Molly 20% or 100% or a million percent personally, but that doesn’t have any bearing on how safe and effective other therapies are at treating the same symptoms.